Preterm Labor Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: P9DBB391EC55EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Preterm Labor Treatment in Global, including the following market information:

Global Preterm Labor Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Preterm Labor Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tocolytic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Preterm Labor Treatment include Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preterm Labor Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Preterm Labor Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Preterm Labor Treatment Market Segment Percentages, by Type, 2021 (%)

• Tocolytic Drugs
• Beta – Mimetic
• Calcium Channel Blockers
• NSAIDS
• Corticosteroids
• Magnesium Sulphate
• Antibiotics

Global Preterm Labor Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Preterm Labor Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Pediatric and Neonatal Clinics
• Nursing Homes
• Pharmacy

Global Preterm Labor Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Preterm Labor Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Preterm Labor Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Preterm Labor Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson and Johnson
• GSK
• AstraZeneca
• Cipla

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Preterm Labor Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Preterm Labor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PRETERM LABOR TREATMENT OVERALL MARKET SIZE

2.1 Global Preterm Labor Treatment Market Size: 2021 VS 2028
2.2 Global Preterm Labor Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Preterm Labor Treatment Players in Global Market
3.2 Top Global Preterm Labor Treatment Companies Ranked by Revenue
3.3 Global Preterm Labor Treatment Revenue by Companies
3.4 Top 3 and Top 5 Preterm Labor Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Preterm Labor Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Preterm Labor Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Preterm Labor Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Preterm Labor Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Preterm Labor Treatment Market Size Markets, 2021 & 2028
  4.1.2 Tocolytic Drugs
  4.1.3 Beta – Mimetic
  4.1.4 Calcium Channel Blockers
  4.1.5 NSAIDS
  4.1.6 Corticosteroids
  4.1.7 Magnesium Sulphate
  4.1.8 Antibiotics
4.2 By Type - Global Preterm Labor Treatment Revenue & Forecasts
  4.2.1 By Type - Global Preterm Labor Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Preterm Labor Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Preterm Labor Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Preterm Labor Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Pediatric and Neonatal Clinics
  5.1.4 Nursing Homes
  5.1.5 Pharmacy
5.2 By Application - Global Preterm Labor Treatment Revenue & Forecasts
  5.2.1 By Application - Global Preterm Labor Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Preterm Labor Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Preterm Labor Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Preterm Labor Treatment Market Size, 2021 & 2028
6.2 By Region - Global Preterm Labor Treatment Revenue & Forecasts
  6.2.1 By Region - Global Preterm Labor Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Preterm Labor Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Preterm Labor Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Preterm Labor Treatment Revenue, 2017-2028
  6.3.2 US Preterm Labor Treatment Market Size, 2017-2028
  6.3.3 Canada Preterm Labor Treatment Market Size, 2017-2028
  6.3.4 Mexico Preterm Labor Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Preterm Labor Treatment Revenue, 2017-2028
  6.4.2 Germany Preterm Labor Treatment Market Size, 2017-2028
  6.4.3 France Preterm Labor Treatment Market Size, 2017-2028
  6.4.4 U.K. Preterm Labor Treatment Market Size, 2017-2028
  6.4.5 Italy Preterm Labor Treatment Market Size, 2017-2028
  6.4.6 Russia Preterm Labor Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Preterm Labor Treatment Market Size, 2017-2028
  6.4.8 Benelux Preterm Labor Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Preterm Labor Treatment Revenue, 2017-2028
  6.5.2 China Preterm Labor Treatment Market Size, 2017-2028
  6.5.3 Japan Preterm Labor Treatment Market Size, 2017-2028
  6.5.4 South Korea Preterm Labor Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Preterm Labor Treatment Market Size, 2017-2028
  6.5.6 India Preterm Labor Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Preterm Labor Treatment Revenue, 2017-2028
  6.6.2 Brazil Preterm Labor Treatment Market Size, 2017-2028
  6.6.3 Argentina Preterm Labor Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Preterm Labor Treatment Revenue, 2017-2028
  6.7.2 Turkey Preterm Labor Treatment Market Size, 2017-2028
  6.7.3 Israel Preterm Labor Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Preterm Labor Treatment Market Size, 2017-2028
  6.7.5 UAE Preterm Labor Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Preterm Labor Treatment Major Product Offerings
  7.1.4 Pfizer Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Preterm Labor Treatment Major Product Offerings
  7.2.4 Novartis Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Preterm Labor Treatment Major Product Offerings
  7.3.4 Merck Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Preterm Labor Treatment Major Product Offerings
  7.4.4 Sanofi Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Johnson and Johnson
  7.5.1 Johnson and Johnson Corporate Summary
  7.5.2 Johnson and Johnson Business Overview
  7.5.3 Johnson and Johnson Preterm Labor Treatment Major Product Offerings
  7.5.4 Johnson and Johnson Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson and Johnson Key News
7.6 GSK
  7.6.1 GSK Corporate Summary
  7.6.2 GSK Business Overview
  7.6.3 GSK Preterm Labor Treatment Major Product Offerings
  7.6.4 GSK Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.6.5 GSK Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Preterm Labor Treatment Major Product Offerings
  7.7.4 AstraZeneca Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Cipla
  7.8.1 Cipla Corporate Summary
  7.8.2 Cipla Business Overview
  7.8.3 Cipla Preterm Labor Treatment Major Product Offerings
  7.8.4 Cipla Preterm Labor Treatment Revenue in Global Market (2017-2022)
  7.8.5 Cipla Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Preterm Labor Treatment Market Opportunities & Trends in Global Market
Table 2. Preterm Labor Treatment Market Drivers in Global Market
Table 3. Preterm Labor Treatment Market Restraints in Global Market
Table 4. Key Players of Preterm Labor Treatment in Global Market
Table 5. Top Preterm Labor Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Preterm Labor Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Preterm Labor Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Preterm Labor Treatment Product Type
Table 9. List of Global Tier 1 Preterm Labor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preterm Labor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Preterm Labor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Preterm Labor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Preterm Labor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Preterm Labor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Preterm Labor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Preterm Labor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Preterm Labor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Preterm Labor Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Preterm Labor Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Preterm Labor Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Preterm Labor Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Preterm Labor Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Preterm Labor Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Preterm Labor Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Preterm Labor Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Preterm Labor Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Preterm Labor Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Preterm Labor Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Preterm Labor Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Preterm Labor Treatment Product Offerings
Table 32. Pfizer Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Preterm Labor Treatment Product Offerings
Table 35. Novartis Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Preterm Labor Treatment Product Offerings
Table 38. Merck Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Preterm Labor Treatment Product Offerings
Table 41. Sanofi Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson and Johnson Corporate Summary
Table 43. Johnson and Johnson Preterm Labor Treatment Product Offerings
Table 44. Johnson and Johnson Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GSK Corporate Summary
Table 46. GSK Preterm Labor Treatment Product Offerings
Table 47. GSK Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Preterm Labor Treatment Product Offerings
Table 50. AstraZeneca Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Cipla Corporate Summary
Table 52. Cipla Preterm Labor Treatment Product Offerings
Table 53. Cipla Preterm Labor Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Preterm Labor Treatment Segment by Type in 2021
Figure 2. Preterm Labor Treatment Segment by Application in 2021
Figure 3. Global Preterm Labor Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preterm Labor Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preterm Labor Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Preterm Labor Treatment Revenue in 2021
Figure 8. By Type - Global Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 12. US Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 24. China Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Preterm Labor Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Preterm Labor Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson and Johnson Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GSK Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cipla Preterm Labor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)